Records containing: Non Small Cell Lung Cancer Stage III
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-19Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
-
CLINICAL_TRIALS study record update · 2025-10-06Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemo RT in Locally Advanced NSCLC Treated With IO (Durvalumab)
-
CLINICAL_TRIALS study record update · 2025-02-18Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2024-02-29Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC Patients - a Phase II Translational and Biomarker Study Investigating PDL1 Positive and Negative Patients
-
CLINICAL_TRIALS study record update · 2024-02-07A Phase II Trial Evaluating Conformational Intensity Modulated Radiotherapy With Concomitant Nivolumab Followed by Nivolumab for Patients With Locally Advanced Non-small Cell Lung Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-19Phase II Trial of Trastuzumab in Combination With Pertuzumab in Pretreated Patients With Non-small Cell Lung Cancer (NSCLC) Harboring a Her2 Mutation and Receiving Docetaxel
-
CLINICAL_TRIALS study record update · 2022-05-19High Intensity Functional Image Guided Vmat Lung Evasion
-
CLINICAL_TRIALS study record update · 2021-06-24National Real-life Study of Tumor Mutational Burden Assessment in First-line Lung Cancer
-
CLINICAL_TRIALS study record update · 2020-12-17A Real-world Study of Consolidation Durvalumab for Stage III Unresectable Non-small Cell Lung Cancer in China and Safety Data on Durvalumab in Chinese Patients With Lung Cancer（PACIFIC-PUMCH-R）
-
CLINICAL_TRIALS study record update · 2020-07-10Efficacy and Safety of Durvalumab Before and After Operation or Durvalumab as Maintenance Therapy After Chemoradiotherapy Against Superior Sulcus Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-05-02Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Change in the Curative-intended, Radical Radiotherapy of Locally Advanced NSCLC
-
CLINICAL_TRIALS study record update · 2014-09-25An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries